P21 Peptide Powder 30mg PP234

Name: P21 Peptide Powder 30mg PP234
Brand: Xi'an Furuida Biotechnology Co., Ltd.
SKU: 2154678452

Shaanxi, ChinaXi'an Furuida Biotechnology Co., Ltd.

US$5.00-20.00

2 Box (MOQ)

Sample price:US$1.00/set.Request sample

Product profile

Customization

Available

Powder

Yes

Customized

Model NO.

P21 Peptide

Certification

GMP, ISO 9001, USP

Suitable for

Elderly, Adult

State

Solid

Purity

>99%

Brand

Furuida

Production Process

Freeze-Dried

Transportation Method

DDP, FedEx, DHL, Usps

Content

99%

Shelf Life

One Year

Production Date

Produced Within Two Weeks

Transport Package

10 Bottles/Box

Specification

Trademark

furuida

Origin

China

Production Capacity

100000 Boxes

Company profile

High Repeat Buyers ChoiceLow MOQ100% Finished Products InspectionCustomization from Samples

Xi'an Furuida Biotechnology Co., Ltd.

Shaanxi, China

Business Type: Trading CompanyExport Year: 2021-12-03Nearest Port: shanghai, tianjin, qingdaoAverage Response Time: ≤0.99hTerms of Payment: T/T, Small-amount payment, LC, etc.International Commercial Terms(Incoterms): FOB, CIF, DDP

AI-Powered supplier vetting

SummaryThe supplier operates in diverse sectors including healthcare products, cosmetics, and food sales but lacks overseas infrastructure like agents or warehouses. Financial metrics over recent years indicate no revenue or profit, suggesting financial instability. Their service and quality management processes lack formal documentation, and innovation capabilities are minimal with no ODM or OEM services. Despite having a quality assurance process, their customization and after-sales service capabilities are limited.

Supplier typeThe supplier's business scope includes sales of health care products, cosmetics, food sales, and technical promotion, indicating a focus on diverse sectors.

After-Sales capabilityThere are no written procedures or records for handling customer complaints, indicating a lack of structured after-sales service capability.

Financial creditThe supplier has shown no operating revenue or profit over the last three years, indicating financial instability.

R&D capabilityThe supplier lacks ODM and OEM services and does not have R&D capabilities with SDK availability, indicating limited innovation capability.

Production capacityThe supplier lacks stock and overseas manufacturing capabilities, suggesting limited production capacity.

Customization capabilityWith only one R&D engineer providing samples, the supplier's customization capability is minimal.